Arrowhead to Present at Upcoming Scientific Conferences
PASADENA, Calif.–(BUSINESS WIRE)–
Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical
company developing targeted RNAi therapeutics, today announced that it
will present at multiple scientific conferences in May.
Scheduled conference presentations include the following:
TIDES 2014 – Providence, RI, May 12-15
May 12, 2014 – An oral presentation titled, “Using Endosomal
Escape Agents for siRNA Delivery in vivo,” will be presented at the
workshop entitled “In vivo Delivery of Therapeutic Oligonucleotides:
Challenges, Considerations and Solutions,” by David Lewis, Ph.D., Chief
Scientific Officer
May 14, 2014 – An oral presentation titled, “Next Generation
Dynamic Polyconjugates for siRNA Delivery in vivo,” will be
presented by Aaron Almeida, Ph.D., Senior Scientist II
10th International Symposium on Polymer Therapeutics – Valencia,
Spain, May 19-21
May 19, 2014 – An oral presentation titled, “Polymer-Based
Vehicles for siRNA Delivery in vivo,” will be presented by David
Rozema, Ph.D., Vice President, Chemistry
ASGCT 17th Annual Meeting – Washington,
DC, May 21-24
May 21, 2014 – An oral presentation titled, “Development of an
siRNA-Based Therapeutic for Chronic HBV Infection Using DPC Technology,”
will be presented by David Lewis, Ph.D., Chief Scientific Officer
About Arrowhead Research Corporation
Arrowhead Research Corporation is a biopharmaceutical company developing
targeted RNAi therapeutics. The company is leveraging its proprietary
drug delivery technologies to develop targeted drugs based on the RNA
interference mechanism that efficiently silences disease-causing genes.
Arrowhead technologies also enable partners to create peptide-drug
conjugates that specifically home to cell types of interest while
sparing off-target tissues. Arrowhead’s pipeline includes clinical
programs in chronic hepatitis B virus and partner-based programs in
obesity and oncology.
For more information please visit http://www.arrowheadresearch.com,
or follow us on Twitter @ArrowRes.
To be added to the Company’s email list to receive news directly, please
send an email to ir@arrowres.com.
Arrowhead Research Corporation
Vince Anzalone, CFA
626-304-3400
ir@arrowres.com
or
Investor
Relations:
The Trout Group
Lauren Glaser
646-378-2972
ir@arrowres.com
or
Media:
Russo
Partners
Martina Schwarzkopf, Ph.D.
212-845-4292
martina.schwarzkopf@russopartnersllc.com
Source: Arrowhead Research Corporation
News Provided by Acquire Media